EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Impact of diagnosis-to-treatment interval on the outcome of patients with acute myeloid leukemia

Samah Nassereddine, Yuan Feng, Jordan Selep, Firas El Chaer, Leah Wells, Ramey Elsarrag, Kimberly Doucette, Vanya Aggarwal, Lacey Williams, Imad Tabbara, Shanshan Liu, Guoquing Diao und 2 weitere

Annals of Hematology · 09.05.2026 · 105 (7)

DOI: 10.1007/s00277-026-07052-7 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Hematology, online erschienen am 09.05.2026. Verfasst von Samah Nassereddine und 13 weiteren Autor:innen. Beteiligte Einrichtung: GW Cancer Center, George Washington University, Washington, DC, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Time-to-Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is considered an oncologic emergency, yet the optimal timing for treatment initiation remains uncertain. We conducted a multi-institutional retrospective study of 698 adults with newly diagnosed AML presenting to four academic centers across the United States. Diagnosis-to-treatment intervals (DTI) were categorized as < 5 days, 5–10 days, and > 10 days. Outcomes were analyzed using multivariable models adjusting for age, treatment intensity, ELN 2017 risk classification, and white blood cell count. Among younger patients, DTI was not associated with differences in survival outcomes. In contrast, older patients demonstrated improved survival with delayed treatment (DTI > 10 days), particularly those with lower white blood cell counts. No adverse effects from treatment delay were observed in younger cohorts. This retrospective study showed that prolonged DTI is associated with improved survival in older adults with newly diagnosed AML, challenging the traditional assumption that immediate therapy universally improves outcomes. These findings underscore the importance of individualized treatment timing in the era of precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteTime-to-TreatmentHumansFemaleRetrospective StudiesAgedMiddle AgedMaleAdultTreatment OutcomeTreatment DelayAged, 80 and overSurvival RateAge Factors

Stichwörter der Autor:innen

Acute myeloid leukemiaDiagnosis-to-treatment intervalInduction chemotherapyMolecular testingPrecision medicineRisk stratificationTargeted therapyTreatment outcomes

Autor:innen und Institutionen

  • GW Cancer Center, George Washington University, Washington, DC, USA.
  • Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
  • Division of Hematology and Oncology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
  • Department of Medicine, Georgetown University, Washington, DC, USA.
  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. Catherine.lai@pennmedicine.upenn.edu.

Zitieren

APA

Nassereddine, S., Feng, Y., Selep, J., El Chaer, F., Wells, L., Elsarrag, R., Doucette, K., Aggarwal, V., Williams, L., Tabbara, I., Liu, S., Diao, G., Percival, M. M., & Lai, C. (2026). Impact of diagnosis-to-treatment interval on the outcome of patients with acute myeloid leukemia. Annals of Hematology, 105(7). https://doi.org/10.1007/s00277-026-07052-7

Vancouver

Nassereddine S, Feng Y, Selep J, El Chaer F, Wells L, Elsarrag R, et al. Impact of diagnosis-to-treatment interval on the outcome of patients with acute myeloid leukemia. Annals of Hematology. 2026;105(7). doi:10.1007/s00277-026-07052-7

BibTeX
@article{Nassereddine2026,
  author = {Nassereddine, Samah and Feng, Yuan and Selep, Jordan and El Chaer, Firas and Wells, Leah and Elsarrag, Ramey and Doucette, Kimberly and Aggarwal, Vanya and Williams, Lacey and Tabbara, Imad and Liu, Shanshan and Diao, Guoquing and Percival, Mary-Elizabeth M and Lai, Catherine},
  title = {Impact of diagnosis-to-treatment interval on the outcome of patients with acute myeloid leukemia},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {7},
  doi = {10.1007/s00277-026-07052-7}
}
Kostenlos starten →